Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity
As regioisomers/bioisosteres of 1a, a 4-phenylbenzamide tranylcypromine (TCP) derivative previously disclosed by us, we report here the synthesis and biological evaluation of some (hetero)arylbenzoylamino TCP derivatives 1b-6, in which the 4-phenyl moiety of 1a was shifted at the benzamide C3 positi...
保存先:
主要な著者: | Rossella Fioravanti (著者), Veronica Rodriguez (著者), Jonatan Caroli (著者), Ugo Chianese (著者), Rosaria Benedetti (著者), Elisabetta Di Bello (著者), Beatrice Noce (著者), Clemens Zwergel (著者), Davide Corinti (著者), Dolores Viña (著者), Lucia Altucci (著者), Andrea Mattevi (著者), Sergio Valente (著者), Antonello Mai (著者) |
---|---|
フォーマット: | 図書 |
出版事項: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
主題: | |
オンライン・アクセス: | Connect to this object online. |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials
著者:: Beatrice Noce, 等
出版事項: (2023) -
LSD1 inhibition by tranylcypromine hydrochloride reduces alkali burn-induced corneal neovascularization and ferroptosis by suppressing HIF-1α pathway
著者:: Qian Deng, 等
出版事項: (2024) -
3-Chloro-N'-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy
著者:: Federica Sarno, 等
出版事項: (2018) -
Strategies that regulate LSD1 for novel therapeutics
著者:: Meng Li, 等
出版事項: (2024) -
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group
著者:: Pasquale Linciano, 等
出版事項: (2021)